Cargando…

Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma

Glaucoma is a neuropathology, often accompanied by an elevated intraocular pressure (IOP), which can lead to blindness. Since DBA/2J mice develop glaucoma, several studies of the physiopathology of glaucoma have been reported in this animal model. It is also known that purinergic receptors are invol...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseca, Begoña, Martínez-Águila, Alejandro, Pérez de Lara, María J., Miras-Portugal, Maria Teresa, Gómez-Villafuertes, Rosa, Pintor, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649148/
https://www.ncbi.nlm.nih.gov/pubmed/29085298
http://dx.doi.org/10.3389/fphar.2017.00719
_version_ 1783272508385918976
author Fonseca, Begoña
Martínez-Águila, Alejandro
Pérez de Lara, María J.
Miras-Portugal, Maria Teresa
Gómez-Villafuertes, Rosa
Pintor, Jesús
author_facet Fonseca, Begoña
Martínez-Águila, Alejandro
Pérez de Lara, María J.
Miras-Portugal, Maria Teresa
Gómez-Villafuertes, Rosa
Pintor, Jesús
author_sort Fonseca, Begoña
collection PubMed
description Glaucoma is a neuropathology, often accompanied by an elevated intraocular pressure (IOP), which can lead to blindness. Since DBA/2J mice develop glaucoma, several studies of the physiopathology of glaucoma have been reported in this animal model. It is also known that purinergic receptors are involved in the pathology of glaucoma by controlling aqueous humor production and drainage and therefore controlling IOP. There are no studies on purinergic receptors in the DBA/2J model of glaucoma and their relation to the development of the pathology, so the aim of this study was to make an approach to the purinergic mechanisms involved in glaucoma. All the experiments were performed using DBA/2J and C57BL/6J mice and investigating P2Y(1), P2Y(2), and P2Y(6) receptors. IOP measurements were made with a non-invasive rebound tonometer, and animals were instilled with diadenosine tetraphosphate (Ap(4)A) and the corresponding purinergic antagonists in order to see their effects on IOP. The expression of mRNA for P2Y(1), P2Y(2), and P2Y(6) purinergic receptors was carried out by quantitative real-time PCR. Additionally, P2Y-receptor expression was performed by immunohistochemical techniques carried out on the ciliary processes. The results showed that IOP decreases when Ap(4)A was instilled and that the expressions of the analyzed purinergic receptors were stable throughout all the ages under study in the C57BL/6J mice (control mice). On the other hand, there were significant changes in the purinergic receptor expression in DBA/2J suggesting that elevated IOP in these animals could be related to an increase of P2Y(2) expression and a decrease in P2Y(1) receptors.
format Online
Article
Text
id pubmed-5649148
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56491482017-10-30 Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma Fonseca, Begoña Martínez-Águila, Alejandro Pérez de Lara, María J. Miras-Portugal, Maria Teresa Gómez-Villafuertes, Rosa Pintor, Jesús Front Pharmacol Pharmacology Glaucoma is a neuropathology, often accompanied by an elevated intraocular pressure (IOP), which can lead to blindness. Since DBA/2J mice develop glaucoma, several studies of the physiopathology of glaucoma have been reported in this animal model. It is also known that purinergic receptors are involved in the pathology of glaucoma by controlling aqueous humor production and drainage and therefore controlling IOP. There are no studies on purinergic receptors in the DBA/2J model of glaucoma and their relation to the development of the pathology, so the aim of this study was to make an approach to the purinergic mechanisms involved in glaucoma. All the experiments were performed using DBA/2J and C57BL/6J mice and investigating P2Y(1), P2Y(2), and P2Y(6) receptors. IOP measurements were made with a non-invasive rebound tonometer, and animals were instilled with diadenosine tetraphosphate (Ap(4)A) and the corresponding purinergic antagonists in order to see their effects on IOP. The expression of mRNA for P2Y(1), P2Y(2), and P2Y(6) purinergic receptors was carried out by quantitative real-time PCR. Additionally, P2Y-receptor expression was performed by immunohistochemical techniques carried out on the ciliary processes. The results showed that IOP decreases when Ap(4)A was instilled and that the expressions of the analyzed purinergic receptors were stable throughout all the ages under study in the C57BL/6J mice (control mice). On the other hand, there were significant changes in the purinergic receptor expression in DBA/2J suggesting that elevated IOP in these animals could be related to an increase of P2Y(2) expression and a decrease in P2Y(1) receptors. Frontiers Media S.A. 2017-10-10 /pmc/articles/PMC5649148/ /pubmed/29085298 http://dx.doi.org/10.3389/fphar.2017.00719 Text en Copyright © 2017 Fonseca, Martínez-Águila, Pérez de Lara, Miras-Portugal, Gómez-Villafuertes and Pintor. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Fonseca, Begoña
Martínez-Águila, Alejandro
Pérez de Lara, María J.
Miras-Portugal, Maria Teresa
Gómez-Villafuertes, Rosa
Pintor, Jesús
Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma
title Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma
title_full Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma
title_fullStr Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma
title_full_unstemmed Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma
title_short Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma
title_sort changes in p2y purinergic receptor expression in the ciliary body in a murine model of glaucoma
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649148/
https://www.ncbi.nlm.nih.gov/pubmed/29085298
http://dx.doi.org/10.3389/fphar.2017.00719
work_keys_str_mv AT fonsecabegona changesinp2ypurinergicreceptorexpressionintheciliarybodyinamurinemodelofglaucoma
AT martinezaguilaalejandro changesinp2ypurinergicreceptorexpressionintheciliarybodyinamurinemodelofglaucoma
AT perezdelaramariaj changesinp2ypurinergicreceptorexpressionintheciliarybodyinamurinemodelofglaucoma
AT mirasportugalmariateresa changesinp2ypurinergicreceptorexpressionintheciliarybodyinamurinemodelofglaucoma
AT gomezvillafuertesrosa changesinp2ypurinergicreceptorexpressionintheciliarybodyinamurinemodelofglaucoma
AT pintorjesus changesinp2ypurinergicreceptorexpressionintheciliarybodyinamurinemodelofglaucoma